Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-018502
Filing Date
2016-08-04
Accepted
2016-08-04 16:05:09
Documents
62
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trov-063016x10q.htm 10-Q 852842
2 EXHIBIT 10.2 trov-0630x16exhibit102.htm EX-10.2 76286
3 EXHIBIT 31.1 trov-063016exhibit311.htm EX-31.1 13473
4 EXHIBIT 32.1 trov-063016exhibit321.htm EX-32.1 6154
  Complete submission text file 0001628280-16-018502.txt   4835994

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT trov-20160630.xml EX-101.INS 851119
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trov-20160630.xsd EX-101.SCH 37755
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trov-20160630_cal.xml EX-101.CAL 61500
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trov-20160630_def.xml EX-101.DEF 205322
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trov-20160630_lab.xml EX-101.LAB 567796
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trov-20160630_pre.xml EX-101.PRE 333615
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-217-5420
Trovagene, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 043721895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 161807370
SIC: 2836 Biological Products, (No Diagnostic Substances)